Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Tailored Interactive Website for Promoting Condom Use Among Young Adults (Youthnet)

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT00183638
First received: September 13, 2005
Last updated: November 26, 2013
Last verified: November 2013
  Purpose

This study will develop and evaluate the effectiveness of tailored web-based messages in promoting condom use among young adults.


Condition Intervention Phase
HIV Infections
Sexually Transmitted Diseases
Behavioral: Internet-based tailored prevention messages
Behavioral: Non-tailored messages
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Randomized Controlled Trial to Establish Efficacy of a Website to Promote Condom Use for Adults Aged 18-25

Resource links provided by NLM:


Further study details as provided by University of Colorado, Denver:

Primary Outcome Measures:
  • Condom use with non main partners [ Time Frame: Measured at Month 3 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Self-efficacy for condom use and condom negotiation [ Time Frame: Measured at Month 3 ] [ Designated as safety issue: No ]
  • Attitudes and norms towards condom use [ Time Frame: Measured at Month 3 ] [ Designated as safety issue: No ]

Enrollment: 1870
Study Start Date: June 2003
Study Completion Date: December 2008
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Participants will receive Internet-based tailored prevention messages
Behavioral: Internet-based tailored prevention messages
Participants will receive five 30-second flash clips promoting condom norms, positive attitudes, self-efficacy, and risk awareness. Participants in the Youthnet program will be asked their gender and ethnicity so they may be assigned to a role model of the same gender and ethnicity via a computer program. This role model will appear online 5 times during the survey to deliver interactive messages that will be tailored to HIV/STD risk reduction and will specifically address attitudes about condom usage.
Other Name: Youthnet
Active Comparator: 2
Participants will receive non-tailored messages containing information on reproductive health
Behavioral: Non-tailored messages
The control program will deliver five general, non-tailored messages containing information on reproductive health not specific to condoms or STDs.

Detailed Description:

Adolescents and young adults are at the greatest risk for acquiring a sexually transmitted disease (STD). Approximately 3 million people between the ages of 18 and 24 become infected with an STD each year. Education about the risks and consequences of unprotected sex is a powerful tool that can be used to prevent or reduce the risk of infection. The program in this study will deliver messages to educate participants about condom use and the risk of STD infection. The study will evaluate the effectiveness of a tailored interactive online risk reduction program versus a standard online risk reduction program in reducing the risk of STD infection in young adults.

Participants in this open-label study will be recruited from one of two clinics in the Denver, Colorado area: Denver Metropolitan Health Clinic or Planned Parenthood of the Rocky Mountains. Participants will be randomly assigned to receive internet-based messages from either the Youthnet program or the control program while filling out a risk assessment survey. Participants in the Youthnet program will be asked their gender and ethnicity so they may be assigned to a role model of the same gender and ethnicity via a computer program. This role model will appear online 5 times during the survey to deliver interactive messages that will be tailored to HIV/STD risk reduction and will specifically address attitudes about condom usage. The control program will deliver 5 general, non-tailored messages containing information on reproductive health not specific to condoms or STDs. Participants will be assessed at baseline and a follow-up session 3 months after enrollment. Frequency of condom use and attitudes toward condom use will be assessed using behavioral scales.

  Eligibility

Ages Eligible for Study:   18 Years to 25 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Client of Denver Metropolitan Health Clinic or Planned Parenthood
  • English-speaking
  • Access to a computer and an existing e-mail account
  • Will be in Denver for at least 4 months

Exclusion Criteria:

  • Not a resident of the Denver metropolitan area
  • No existing e-mail address
  • No access to a computer
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00183638

Locations
United States, Colorado
University of Colorado Health Sciences Center
Aurora, Colorado, United States, 80045-0508
Sponsors and Collaborators
University of Colorado, Denver
Investigators
Principal Investigator: Sheana S. Bull, PhD University of Colorado, Denver
  More Information

No publications provided

Responsible Party: University of Colorado, Denver
ClinicalTrials.gov Identifier: NCT00183638     History of Changes
Other Study ID Numbers: 02-0764a, R01MH063690, DAHBR 9A-ASI
Study First Received: September 13, 2005
Last Updated: November 26, 2013
Health Authority: United States: Federal Government

Keywords provided by University of Colorado, Denver:
Internet
Interactive Computer Program
HIV Prevention

Additional relevant MeSH terms:
Acquired Immunodeficiency Syndrome
HIV Infections
Sexually Transmitted Diseases
Genital Diseases, Female
Genital Diseases, Male
Immune System Diseases
Immunologic Deficiency Syndromes
Infection
Lentivirus Infections
RNA Virus Infections
Retroviridae Infections
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases

ClinicalTrials.gov processed this record on November 24, 2014